Twist Bioscience (TWST) Total Current Liabilities (2018 - 2026)

Twist Bioscience has disclosed Total Current Liabilities across 9 years of filings, most recently posting $120.0 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 60.02% year-over-year to $120.0 million; the TTM figure through Mar 2026 stood at $120.0 million (up 60.02% YoY), while the FY2025 annual figure was $91.4 million, up 28.73% from the prior year.
• Total Current Liabilities climbed to $120.0 million in Q1 2026, from $80.4 million in the prior quarter.
• Over the last five years, Total Current Liabilities for TWST reached as high as $120.0 million in Q1 2026 and fell as low as $65.2 million in Q4 2023.
• The 5-year median for Total Current Liabilities is $75.0 million (2025), against an average of $80.7 million.
• Annual changes were most pronounced in 2022 — Total Current Liabilities soared 109.27% — and 2023, when it decreased 22.2%.
• A 5-year view of Total Current Liabilities shows it stood at $83.8 million in 2022, then fell by 22.2% to $65.2 million in 2023, then grew by 6.77% to $69.6 million in 2024, then advanced by 15.5% to $80.4 million in 2025, then surged by 49.15% to $120.0 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $120.0 million, $80.4 million, and $91.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.